AzTrials
AzTrials

Postoperative HypoxemiaNCT07545642

Effect of Lateral Versus Supine Positions on Postoperative Hypoxemia

A study testing Lateral decubitus position group (Group L) and Supine position group (Group S) in people with Postoperative Hypoxemia, run by General Hospital of Ningxia Medical University at 1 site in China.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Using prospective real-world data, this study aims to determine whether the lateral decubitus position reduces the incidence of post-procedure hypoxemia in patients undergoing painless gastroscopy/colonoscopy, thereby providing a simple, non-invasive, and low-cost optimization strategy for clinical practice. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Postoperative Hypoxemia
What is being tested?
Lateral decubitus position group (Group L) and Supine position group (Group S)
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
960 participants
Where
1 siteChina
Study dates
22 Apr 2026to 30 Jul 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age ≥ 18 years.
  • Both sexes.
  • American Society of Anesthesiologists (ASA) physical status classification I-III.
  • Scheduled for combined painless esophagogastroduodenoscopy/colonoscopy or either of the two procedures.
  • Ability to understand the study protocol and provide written informed consent.
  • A broad set of inclusion criteria was adopted to enroll a patient population that better reflects routine clinical practice. The study aimed to enhance the generalizability of the findings by including patients with various comorbidities, such as preprocedural hypoxemia (room-air SpO₂ ≤ 90%), history of pulmonary surgery, obstructive sleep apnea (OSA), and other pulmonary conditions (including asthma, COPD, chronic bronchitis, emphysema, and pulmonary bullae).

Who cannot join

  • Severe cardiovascular or cerebrovascular diseases.
  • Pregnant patients.
  • History of hypersensitivity to ciprofol.
  • Withdrawal Criteria:
  • Endotracheal intubation required during the procedure.
  • Voluntary withdrawal requested by the patient or their legal representative.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Xiaoyong Wei, Degree contact

86-951-674-3252

weixy9912@126.com

China1 site, 1 recruiting
  • General hospital of Ningxia medical university, Yinchuan, Ningxia

    Yinchuan, Ningxia, 750001

    Xiaoyong Wei, Degree, 86-951-674-3252, weixy9912@126.cm

    Recruiting

Other trials in China

About this study

Official title: Effect of Lateral Versus Supine Positions on Postoperative Hypoxemia in Patients Undergoing Painless Gastroscopy and Colonoscopy: A Prospective Randomized Controlled Study

Using prospective real-world data, this study aims to determine whether the lateral decubitus position reduces the incidence of post-procedure hypoxemia in patients undergoing painless gastroscopy/colonoscopy, thereby providing a simple, non-invasive, and low-cost optimization strategy for clinical practice.

Read the detailed description

Painless gastroscopy and colonoscopy have become essential modalities for the screening and diagnosis of digestive tract diseases, with their utilization increasing annually. However, hypoxemia remains the most common complication during these procedures, with reported incidences ranging widely from 1.8% to 69%. Severe hypoxemia can lead to adverse outcomes, including arrhythmias, hemodynamic decompensation, and hypoxic brain injury. Consequently, developing effective strategies to prevent hypoxemia in patients undergoing sedation for gastrointestinal (GI) endoscopy is of significant clinical value.

Current clinical research has primarily focused on hypoxemia occurring during the endoscopic procedure itself, whereas there is a paucity of high-quality evidence regarding the incidence and preventive measures of hypoxemia during the recovery phase. Specifically, the impact of body positioning on post-procedural hypoxemia remains largely unexplored. Emerging evidence suggests that the lateral decubitus position significantly reduces the incidence of hypoxemia during adult sedation. Anatomically, in the supine position, residual sedative effects combined with gravity cause the tongue and soft palate-structures lacking bony support-to collapse posteriorly, leading to upper airway obstruction. Conversely, the lateral position helps maintain a patent airway by preventing this collapse and optimizing the ventilation-perfusion (V/Q) matching, thereby stabilizing oxygenation.

Despite this theoretical basis, prospective studies investigating the effect of body positioning on recovery-phase hypoxemia in real-world settings are lacking. Therefore, this study hypothesizes that the lateral decubitus position reduces the incidence of recovery-phase hypoxemia compared to the supine position. Using prospective real-world data, we aim to validate this hypothesis and provide a simple, non-invasive, and cost-effective optimization strategy for clinical practice.

Being tested
Lateral decubitus position group (Group L), Supine position group (Group S)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Lateral decubitus position group (Group L)Procedure or surgery

    Upon admission to the Post-Anesthesia Care Unit (PACU), an independent researcher (attending anesthesiologist) assessed the patient using the Ramsay Sedation Scale (1: anxious and agitated; 2: awake, calm, and cooperative; 3: drowsy but responsive to verbal commands; 4: asleep but responsive to tactile stimulation or pain; 5: asleep with a sluggish response to stimulation; 6: deep sleep with no response). Patients in the Lateral Group (Group L) were maintained in the predetermined left lateral position. Standard monitoring was applied, and nasal cannula oxygen was administered at 2 L/min. If SpO₂ remained >95% for at least 5 minutes, oxygen was discontinued for observation. To ensure strict adherence to the protocol, an independent researcher continuously monitored and verified patient positioning (corrections were made only if the patient rolled unconsciously). Patients were evaluated using the Aldrete discharge scoring system; discharge from the PACU occurred when a score of >9 was a

  • Supine position group (Group S)Procedure or surgery

    Upon admission to the Post-Anesthesia Care Unit (PACU), an independent researcher (attending anesthesiologist) assessed the patient using the Ramsay Sedation Scale (1: anxious and agitated; 2: awake, calm, and cooperative; 3: drowsy but responsive to verbal commands; 4: asleep but responsive to tactile stimulation or pain; 5: asleep with a sluggish response to stimulation; 6: deep sleep with no response). Patients in the Supine Group (Group S) were turned from the predetermined lateral position to the supine position without a head pillow (head-of-bed elevation at 0 degrees). Standard monitoring was applied, and nasal cannula oxygen was administered at 2 L/min. If SpO₂ remained >95% for at least 5 minutes, oxygen was discontinued for observation. To ensure strict adherence to the protocol, an independent researcher continuously monitored and verified patient positioning (corrections were made only if the patient rolled unconsciously). Patients were evaluated using the Aldrete discharge

Study groups in NCT07545642
Study groupRoleWhat they receive
Supine position group (Group S)ExperimentalThe patient was turned from the predetermined left lateral position to the supine position without a head pillow (head-of-bed elevation at 0 degrees)
Receives: Procedure: Supine position group (Group S)
Lateral decubitus position group (Group L)ExperimentalUpon arrival in the post-anesthesia care unit (PACU), the patient was kept in the left lateral decubitus position
Receives: Procedure: Lateral decubitus position group (Group L)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of recovery-phase hypoxemia,

    Proportion of participants experiencing hypoxemia (SpO₂ ≤ 90% lasting >10 seconds) during the post-procedure recovery period.

    Measured: From PACU admission until discharge, assessed up to 30 minutes

Secondary outcomes (12)
  1. Incidence of Severe Hypoxemia During Recovery

    Proportion of participants experiencing severe hypoxemia, defined as pulse oxygen saturation (SpO₂) < 85% lasting >10 seconds during the post-procedure recovery period.

    Measured: From PACU admission until discharge, assessed up to 30 minutes

  2. Incidence of Subclinical Respiratory Depression during Recovery

    Proportion of participants experiencing subclinical respiratory depression, defined as any episode of pulse oxygen saturation (SpO₂) in the range of 90% to <95% (inclusive of 90%, exclusive of 95%) during the post-procedure recovery period.

    Measured: From PACU admission until discharge, assessed up to 30 minutes.

  3. Overall Incidence of Airway Intervention During Recovery

    Proportion of participants requiring any grade of airway intervention (increase oxygen flow, chin lift, mask ventilation, or reintubation) during recovery.

    Measured: From PACU admission until discharge, assessed up to 30 minutes

  4. Cough Severity Grade During Recovery

    Severity of cough assessed during the recovery period, graded as:

    Grade I: No cough, smooth breathing; Grade II: Single mild cough; Grade III: Multiple coughs lasting <15 seconds; Grade IV: Continuous coughing lasting ≥15 seconds. Reported as the proportion of participants reaching each grade (I-IV).

    Measured: From PACU admission until discharge, assessed up to 30 minutes

  5. Length of Stay in Post-Anesthesia Care Unit (PACU)

    Time from admission to the post-anesthesia care unit (PACU) until discharge criteria are met (modified Aldrete score ≥9 on three consecutive assessments), recorded in minutes.

    Measured: From PACU admission until discharge

  6. Respiratory Comfort Score During Recovery

    Patient-reported respiratory comfort assessed using a Numerical Rating Scale (NRS) ranging from 0 (worst discomfort) to 10 (greatest comfort)

    Measured: From PACU admission until discharge, assessed up to 30 minutes

  7. PACU Nurse Satisfaction Score

    Nurse-assessed satisfaction with patient respiratory stability and overall recovery management, rated using a Numerical Rating Scale (NRS) ranging from 0 (lowest satisfaction) to 10 (highest satisfaction), recorded at patient discharge from the post-anesthesia care unit.

    Measured: From PACU admission until discharge, assessed up to 30 minutes

  8. Incidence of Tachycardia During Recovery

    Proportion of participants experiencing tachycardia (heart rate >100 beats/min) during the post-procedure recovery period.

    Measured: From PACU admission until discharge, assessed up to 30 minutes

  9. Incidence of Bradycardia During Recovery

    Proportion of participants experiencing bradycardia (heart rate <50 beats/min) during recovery.

    Measured: From PACU admission until discharge, assessed up to 30 minutes

  10. Incidence of Hypotension During Recovery

    Proportion of participants experiencing hypotension (systolic blood pressure <80 mmHg) during recovery.

    Measured: From PACU admission until discharge, assessed up to 30 minutes

  11. Incidence of Nausea or Vomiting During Recovery

    Proportion of participants experiencing nausea (subjective complaint) or vomiting (objective expulsion of gastric contents) during recovery.

    Measured: From PACU admission until discharge, assessed up to 30 minutes

  12. Incidence of Laryngospasm During Recovery

    Proportion of participants experiencing laryngospasm (acute upper airway obstruction with stridor/inability to ventilate, resolving with intervention) during recovery.

    Measured: From PACU admission until discharge, assessed up to 30 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Apr 2026
  2. Study start22 Apr 2026
  3. Primary completion18 Jun 2026
  4. Study completion30 Jul 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
960 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07545642
Sponsor's protocol ID
dywe0001
Status last verified
Apr 2026
First submitted
7 Apr 2026
Last updated
24 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Lateral decubitus position group (Group L) and Supine position group (Group S) in people with Postoperative Hypoxemia, run by General Hospital of Ningxia Medical University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 24 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Xiaoyong Wei, Degree (86-951-674-3252, weixy9912@126.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of recovery-phase hypoxemia, (time frame: From PACU admission until discharge, assessed up to 30 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in